自胆固醇轴重塑支持结质瘤恶性进展和化学抵抗
bioRxiv : the preprint server for biology
|January 16, 2026
概括
质瘤的进展涉及自断和改变胆固醇代谢,有助于特莫索洛米德耐药性. 用他类药物向胆固醇通路并没有克服质母细胞瘤中的这种抵抗.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 分子代谢的分子代谢.
背景情况:
- 质瘤的进展和对泰莫索洛米德 (TMZ) 的耐药性带来了重大的临床挑战.
- 自失调和改变的胆固醇代谢与瘤的攻击性有关.
研究的目的:
- 研究在质瘤进展和TMZ耐药性期间自和胆固醇代谢的协调重塑.
- 阐明质母细胞瘤治疗耐受性背后的机制.
主要方法:
- 对天体细胞瘤和质母细胞瘤样本进行组织微阵列分析.
- 研究自流,胆固醇合成途径 (FDPS,SREBP-2,LDL-R) 和TMZ抗性细胞中的生物能量.
- 综合性脂质学分析和simvastatin治疗以评估胆固醇通路抑制.
主要成果:
- 渐进的自细胞积累和自细胞流失与质瘤等级相关.
- 耐TMZ的质母细胞瘤细胞表现出上皮细胞到介质母细胞的过渡,静止和线粒体功能的改变.
- 损伤的自抑制胆固醇合成,而脂管学揭示了耐药细胞中特定胆固醇的积累.
- 辛巴斯塔丁治疗改变了胆固醇的特征,但没有恢复自或TMZ敏感性.
结论:
- 自和胆固醇代谢的协调失调是质瘤进展和TMZ耐药性的标志.
- 治疗耐受性质母细胞瘤细胞具有独特的代谢表型,其特征是有限的生物能量容量.
- 用simvastatin准美瓦酸途径不足以克服质母细胞瘤中的TMZ抵抗.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K


